scholarly journals Application of a free radical scavenger edaravone in patients with subarachnoid hemorrhage (review)

2021 ◽  
Vol 17 (7) ◽  
pp. 10-14
Author(s):  
O.A. Halushko ◽  
T.S. Zahranychnyi

Background. The free radical scavenger edaravon helps to reduce the area of ischemic injury and improve the long-term effects of stroke and is therefore widely used in the treatment of ischemic stroke. However, the role of edaravone in the treatment of patients with subarachnoid hemorrhage has not yet been clarified. The purpose was to investigate the feasibility and effectiveness of the use of the free radical scavenger xavron (edaravon) in the treatment of patients with subarachnoid hemorrhage. Materials and methods. A search was conducted for studies and systematic reviews for the keywords: “acute stroke”; “subarachnoid hemorrhage”, “hemorrhagic transformation”, “edaravon” in the Google Scholar database published between 2003 and 2021. Results. The use of edaravone in patients with subarachnoid hemorrhage was accompanied by the activation of anti-inflammatory and reduction of pro-inflammatory peptides, activation of anti-apoptotic mechanisms, reduction of lipid peroxidation, oxidative trauma, the permeability of the brain swelling. Conclusions. The main effects of edaravon (xavron) have been found to reduce neurological deficits, accelerate the recovery of neurological disorders, and improve functional outcomes. Thus, the introduction of edaravone in patients with subarachnoid hemorrhage has been proven to be reliably effective and safe.

2021 ◽  
pp. 28-36
Author(s):  
O.A. Halushko

BACKGROUND. The free radical scavenger edaravone helps to reduce the area of ischemic injury and improve the longterm effects of stroke, and is therefore widely used in the treatment of ischemic stroke. However, the role of edaravone in the treatment of hemorrhagic stroke patients has not yet been clarified. OBJECTIVE. To investigate the feasibility and effectiveness of the use of the free radical scavenger edaravone in the treatment of patients with acute hemorrhagic stroke. MATERIALS AND METHODS. A search was conducted for studies and systematic reviews for the keywords “acute stroke”, “intracerebral hemorrhage”, “subarachnoid hemorrhage”, “hemorrhagic transformation”, “edaravone” in the Google Scholar database published between 2003 and 2020. RESULTS. The use of edaravone in patients with intracerebral hemorrhage was accompanied by activation of anti-inflammatory and reduction of pro-inflammatory peptides, activation of anti-apoptotic mechanisms, reduction of lipid peroxidation and oxidative trauma, reduction of permeability of the hematocenosis. CONCLUSIONS. The main effects of edaravone have been to reduce neurological deficits, accelerate the rate of recovery of neurological disorders, and improve functional outcomes. Thus, the introduction of edaravone in patients with hemorrhagic stroke has proven to be reliably effective and safe.


2020 ◽  
Vol 10 (01) ◽  
pp. e104-e109
Author(s):  
Antonio Molina-Carballo ◽  
Antonio Emilio Jerez-Calero ◽  
Antonio Muñoz-Hoyos

AbstractMelatonin, produced in every cell that possesses mitochondria, acts as an endogenous free radical scavenger, and improves energetic metabolism and immune function, by complex molecular crosstalk with other intracellular compounds. There is greatly increasing evidence regarding beneficial effects of acute and chronic administration of high melatonin doses, in infectious, developmental, and degenerative pathologies, as an endothelial cell and every cell protectant.


2009 ◽  
Vol 29 (4) ◽  
pp. 715-725 ◽  
Author(s):  
Toru Yamashita ◽  
Tatsushi Kamiya ◽  
Kentaro Deguchi ◽  
Toshiki Inaba ◽  
Hanzhe Zhang ◽  
...  

In the ischemic brain, reperfusion with tissue plasminogen activator (tPA) sometimes causes catastrophic hemorrhagic transformation (HT); however, the mechanism remains elusive. Here, we show that the basement membrane, and not the endothelial cells, is vulnerable to ischemic/reperfusion injury with tPA treatment. We treated a spontaneously hypertensive rat model of middle cerebral artery occlusion (MCAO) with vehicle alone, tPA alone, or a free radical scavenger, edaravone, plus tPA. Light and electron microscopic analyses of each microvascular component revealed that the basement membrane disintegrated and became detached from the astrocyte endfeet in tPA-treated animals that showed HT. On the other hand, edaravone prevented the dissociation of the neurovascular unit, dramatically decreased the HT, and improved the neurologic score and survival rate of the tPA-treated rats. These results suggest that the basement membrane that underlies the endothelial cells is a key structure for maintaining the integrity of the neurovascular unit, and a free-radical scavenger can be a viable agent for inhibiting tPA-induced HT.


1986 ◽  
Vol 41 (5) ◽  
pp. 551-556 ◽  
Author(s):  
John C. Coles ◽  
S. Naeem Ahmed ◽  
Harendra U. Mehta ◽  
John C.E. Kaufmann

2005 ◽  
Vol 33 (5) ◽  
pp. 1057-1063 ◽  
Author(s):  
Martin Matejovic ◽  
Ales Krouzecky ◽  
Vendula Martinkova ◽  
Richard Rokyta ◽  
Jaroslav Radej ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document